Younes, Hadi
Sohns, Christian
Akoum, Nazem
Feng, Han
Tsakiris, Eli
Hajjar, Abdel Hadi El
Donnellan, Eoin
Pandey, Amitabh C.
Lim, Chanho
Bidaoui, Ghassan
Mekhael, Mario
Noujeim, Charbel
Chouman, Nour
Assaf, Ala
Shamaileh, Ghaith
Polo, Francisco Tirado
Bsoul, Mayana
Dagher, Lilas
Kreidieh, Omar
Rao, Swati
Sommer, Philipp
Forkmann, Mathias
Brachmann, Johannes
Marrouche, Nassir
Mahnkopf, Christian
Article History
Received: 15 April 2024
Accepted: 20 May 2024
First Online: 7 June 2024
Declarations
:
: NM reports having received consulting fees from Biosense Webster, Boston Scientific, and AtriCure. NM also reports being a speaker for Abbott, Biosense Webster, AtriCure, and Sanofi. NM also reports receiving research support Abbott, Medtronic, Biosense Webster, Siemens, GE, Boston Scientific, Sanofi, and Samsung. NM also reports having a family member as the CEO of Cardiac Designs. NM also reports being the founder of Marrek, being named in a patent issued for MRI fibrosis imaging, and being a previous shareholder of Cardiac Designs. All other co-authors have no relevant conflict of interest. The DECAAF II trial was funded by Medtronic, GE, Siemens, Boston Scientific, Biosense Webster, and Abbott.